Literature DB >> 22126511

Breast cancer prevention and control programs in Malaysia.

Maznah Dahlui1, Sofea Ramli, Awang M Bulgiba.   

Abstract

Breast cancer is the most common cancer in Malaysian females. The National Cancer Registry in 2003 and 2006 reported that the age standardized incidence of breast cancer was 46.2 and 39.3 per 100,000 populations, respectively. With the cumulative risk at 5.0; a woman in Malaysia had a 1 in 20 chance of developing breast cancer in her lifetime. The incidence of cancer in general, and for breast cancer specifically was highest in the Chinese, followed by Indians and Malays. Most of the patients with breast cancers presented at late stages (stage I: 15.45%, stage II: 46.9%, stage III: 22.2% and stage IV: 15.5%). The Healthy Lifestyles Campaign which started in the early nineties had created awareness on breast cancer and after a decade the effort was enhanced with the Breast Health Awareness program to promote breast self examination (BSE) to all women, to perform annual clinical breast examination (CBE) on women above 40 and mammogram on women above 50. The National Health Morbidity Survey in 2006 showed that the prevalence rate of 70.35% by any of three methods of breast screening; 57.1% by BSE, 51.8% by CBE and 7.6% by mammogram. The current screening policy for breast cancer focuses on CBE whereby all women at the age of 20 years and above must undergo breast examination by trained health care providers every 3 years for age between 20-39 years, and annually for age 40 and above. Several breast cancer preventive programs had been developed by various ministries in Malaysia; among which are the RM50 subsidy for mammogram by the Ministry of Women, Family and Community Development and the SIPPS program (a call-recall system for women to do PAP smear and CBE) by the Ministry of Health. Measures to increase uptake of breast cancer screening and factors as to why women with breast cancer present late should be studied to assist in more development of policy on the prevention of breast cancer in Malaysia.

Entities:  

Mesh:

Year:  2011        PMID: 22126511

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  10 in total

Review 1.  Advances in breast cancer screening modalities and status of global screening programs.

Authors:  Chenyu Luo; Le Wang; Yuhan Zhang; Ming Lu; Bin Lu; Jie Cai; Hongda Chen; Min Dai
Journal:  Chronic Dis Transl Med       Date:  2022-05-25

2.  Breast cancer in South East Asia: comparison of presentation and outcome between a middle income and a high income country.

Authors:  Nakul Saxena; Mikael Hartman; Nirmala Bhoo-Pathy; Jennifer N W Lim; Tar-Ching Aw; Philip Iau; Nur Aishah Taib; Soo-Chin Lee; Cheng-Har Yip; Helena M Verkooijen
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

3.  Clinical breast examination as the recommended breast cancer screening modality in a rural community in Malaysia; what are the factors that could enhance its uptake?

Authors:  Nik Daliana Nik Farid; Norlaili Abdul Aziz; Nabilla Al-Sadat; Mariam Jamaludin; Maznah Dahlui
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

4.  Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia.

Authors:  Zobaida Edib; Verasingam Kumarasamy; Norlia Binti Abdullah; A M Rizal; Sami Abdo Radman Al-Dubai
Journal:  Health Qual Life Outcomes       Date:  2016-02-22       Impact factor: 3.186

5.  Barriers to early presentation of self-discovered breast cancer in Singapore and Malaysia: a qualitative multicentre study.

Authors:  Jennifer N W Lim; Barbara Potrata; Leonardo Simonella; Celene W Q Ng; Tar-Ching Aw; Maznah Dahlui; Mikael Hartman; Rifhan Mazlan; Nur Aishah Taib
Journal:  BMJ Open       Date:  2015-12-21       Impact factor: 2.692

6.  miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.

Authors:  Qing Li; Jiangtao Liu; Yanli Jia; Tingting Li; Mei Zhang
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.682

7.  Knowledge, attitude, and practice of breast self-examination amongst female IT professionals in Silicon Valley of India.

Authors:  Samarth Kalliguddi; Sahithi Sharma; Chaitali A Gore
Journal:  J Family Med Prim Care       Date:  2019-02

8.  Evaluation of Bioactive Compounds, Pharmaceutical Quality, and Anticancer Activity of Curry Leaf (Murraya koenigii L.).

Authors:  Ali Ghasemzadeh; Hawa Z E Jaafar; Asmah Rahmat; Thiyagu Devarajan
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-16       Impact factor: 2.629

9.  Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1'S-1'-acetoxychavicol acetate analogs on MDA-MB-231 breast cancer cells.

Authors:  Su Ki Liew; Mohamad Nurul Azmi; Lionel LA In; Khalijah Awang; Noor Hasima Nagoor
Journal:  Drug Des Devel Ther       Date:  2017-09-18       Impact factor: 4.162

10.  Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.

Authors:  Abdullah Saleh Al-Wajeeh; Salizawati Muhamad Salhimi; Majed Ahmed Al-Mansoub; Imran Abdul Khalid; Thomas Michael Harvey; Aishah Latiff; Mohd Nazri Ismail
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.